Debyani Chakravarty

Memorial Sloan Kettering Cancer Center — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

66h-index65.3kcitations269works5.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(131), Lung Cancer Treatments and Mutations(43), Genetic factors in colorectal cancer(36), Genomics and Rare Diseases(36), RNA modifications and cancer(24)

Publications253 total

Precision Oncology: 2025 in Review
Cancer Discovery·2025
Figure s2 from Comprehensive Molecular Characterization of Gallbladder Carcinoma and Potential Targets for Intervention
2025Open Access
Figure S1 from Comprehensive Molecular Characterization of Gallbladder Carcinoma and Potential Targets for Intervention
2025Open Access
supplementary legend1 from Comprehensive Molecular Characterization of Gallbladder Carcinoma and Potential Targets for Intervention
2025Open Access
Supplementary Data1 from Comprehensive Molecular Characterization of Gallbladder Carcinoma and Potential Targets for Intervention
2025Open Access
Abstract B044: Black and Hispanic patients with pancreatic ductal adenocarcinoma (PDAC) have worse overall survival than Asian and White patients with PDAC, despite having more favorable genetic profiles
Cancer Research·2025
AI cancer driver mutation predictions are valid in real-world data
Nature Communications·2025· 1 citedOpen Access
Abstract A097: Impact of socioeconomic status on survival outcomes in patients with stage IV pancreatic adenocarcinoma: A race/ethnicity controlled analysis
Cancer Epidemiology Biomarkers & Prevention·2025
Supplementary Table 2 from Improving Global Access to Genomic Profiling in Rare Pediatric Cancers
2025Open Access
Supplementary Figure 1 from Improving Global Access to Genomic Profiling in Rare Pediatric Cancers
2025Open Access
Data from Improving Global Access to Genomic Profiling in Rare Pediatric Cancers
2025Open Access
Supplementary Table 1 from Improving Global Access to Genomic Profiling in Rare Pediatric Cancers
2025Open Access
Supplementary Table 3 from Improving Global Access to Genomic Profiling in Rare Pediatric Cancers
2025Open Access
Supplementary Figure 2 from Improving Global Access to Genomic Profiling in Rare Pediatric Cancers
2025Open Access
Expanding the utility of precision oncology knowledge bases
Nature reviews. Cancer·2025· 1 cited
Genomic characterization of anal canal squamous cell carcinoma (ASCC) and outcomes on matched targeted therapy.
Journal of Clinical Oncology·2025
OncoKB: Automated annotation of the pathogenicity and treatment implications of germline mutations in cancer.
Journal of Clinical Oncology·2025
Improving Global Access to Genomic Profiling in Rare Pediatric Cancers
Clinical Cancer Research·2025Open Access
Abstract LB081: Carboxyamidotriazole orotate (CTO) with temozolomide (TMZ) for recurrent high-grade gliomas (rHGG) and in combination with TMZ/RT->TMZ in newly diagnosed glioblastoma (ndGBM): Long term follow-up of phase IB trial
Cancer Research·2025
Abstract 1066: OncoKBTM, MSK’s precision oncology knowledge base: 2024 updates
Cancer Research·2025
page 1 of 13Next →

Frequent Co-authors

Ritika Kundra(33), Marc Ladanyi(30), Nikolaus Schultz(30), Ilya Shmulevich(26), Walid K. Chatila(26), Brady Bernard(24), John N. Weinstein(24), Vésteinn Thórsson(24), Gordon B. Mills(23), Gad Getz(23), Joshua Armenia(23), Zachary Heins(23), Sheila M. Reynolds(22), Kalle Leinonen(21), Heidi J. Sofia(21), Michael S. Lawrence(21), Thomas J. Giordano(21), Varsha Dhankani(21), Yuexin Liu(21), Ino de Bruijn(21)